Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients

This study determined the effects of a novel combination of vitamin D and probiotic on metabolic and clinical symptoms in chronic schizophrenia.This trial was conducted among 60 patients with chronic schizophrenia to receive either 50,000 IU vitamin D3 every 2 weeks plus 8 × 109 CFU/day probiotic (n = 30) or placebo (n = 30) for 12 weeks.Vitamin D and probiotic co-supplementation was associated with a significant improvement in the general (-...